CLINICAL_TRIALS
trial_result
· 2025-12-03
Clinical Trial Update: A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease [Phase 2]
Summary
A Phase 2a trial evaluating REM0046127 in mild to moderate Alzheimer's disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: reMYND | Conditions: Alzheimer Disease | Phase 2 | Status: TERMINATED